Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation

INTRODUCTION: BEAM (carmustine, etoposide, cytarabine, melphalan) is the most frequently used high-dose chemotherapy regimen for patients with lymphoma referred for autologous haematopoietic cell transplantation (autoHCT). Recently, a novel conditioning protocol containing bendamustine instead of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankiewicz, Andrzej, Saduś-Wojciechowska, Maria, Najda, Jacek, Czerw, Tomasz, Mendrek, Włodzimierz, Sobczyk-Kruszelnicka, Małgorzata, Soska, Katarzyna, Ociepa, Małgorzata, Hołowiecki, Jerzy, Giebel, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103227/
https://www.ncbi.nlm.nih.gov/pubmed/30150889
http://dx.doi.org/10.5114/wo.2018.77046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103227/
https://www.ncbi.nlm.nih.gov/pubmed/30150889
http://dx.doi.org/10.5114/wo.2018.77046

Ejemplares similares